These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 8336397

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Clinical significance of urinary FDP-E measured by latex photometric immunoassay (LPIA) in the renal disease].
    Kaizu K, Ito Y, Uriu K, Komine N, Hashimoto O, Eto S.
    Nihon Jinzo Gakkai Shi; 1991 Apr; 33(4):365-71. PubMed ID: 1875556
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Urinary cross-linked FDP in various renal diseases].
    Inuma H.
    Nihon Jinzo Gakkai Shi; 1994 Feb; 36(2):146-57. PubMed ID: 8139147
    [Abstract] [Full Text] [Related]

  • 5. [Intraglomerular coagulation and fibrinolysis in human primary glomerular diseases].
    Shibata K, Dohi K, Fujii Y, Ishikawa H.
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):719-29. PubMed ID: 1770632
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Significance of urinary fibrin/fibrinogen degradation products (FDP) D-dimer measured by a highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases.
    Shibata T, Magari Y, Kamberi P, Ishii T, Tomo T, Yasumori R, Nasu M.
    Clin Nephrol; 1995 Aug; 44(2):91-5. PubMed ID: 8529315
    [Abstract] [Full Text] [Related]

  • 8. [Significance of urinary fibrin/fibrinogen degradation product (FDP) D-dimer measured by highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases].
    Shibata T, Magari Y, Mizunaga S, Okabe E, Sumie A, Ishii T, Tomo T, Yasumori R, Nasu M.
    Nihon Jinzo Gakkai Shi; 1994 Jul; 36(7):805-12. PubMed ID: 8072218
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Serum FDP assay with latex photometric immunoassay and its analysis by immunoblotting].
    Okumura N, Kagiya H, Saito H, Katsuyama T, Kanai M.
    Rinsho Byori; 1991 Jan; 39(1):76-82. PubMed ID: 2008047
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Significance of urinary fibrin/fibrinogen degradation products in renal diseases measured by a highly sensitive ELISA.
    Shibata T, Magari Y, Perparim K, Sumie A, Ishii T, Tomo T, Sato J, Yasumori R, Nasu M.
    Nephron; 1995 Jan; 69(1):54-8. PubMed ID: 7891798
    [Abstract] [Full Text] [Related]

  • 15. [Clinical significance of FDP-E analysis in blood coagulation and fibrinolysis tests].
    Horiuchi N, Aoki Y, Terada H.
    Nihon Rinsho; 1989 Dec; 48 Suppl():896-900. PubMed ID: 2622026
    [No Abstract] [Full Text] [Related]

  • 16. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
    Scott WL, Francis CW, Knutson DW, Marder VJ.
    J Lab Clin Med; 1986 Jun; 107(6):534-43. PubMed ID: 3519810
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparisons of hemagglutination inhibition, staphylococcal clumping, and latex agglutination tests for canine fibrinolytic degradation products.
    Chen JP, Williams TK, Legendre AM.
    Am J Vet Res; 1981 Dec; 42(12):2049-52. PubMed ID: 7340573
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.